Amarantus BioScience Holdings, Inc.
Amarantus BioScience Holdings, Inc. (AMBS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · AMBS · as of Jun 9, 2026
Key Statistics
Explore Amarantus BioScience Holdings, Inc. Data
ambs stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
ambs competitorsAMBS
ACBM
AFFY
BSSP
DECN
ENDVStock Performance
Full HistoryAbout Amarantus BioScience Holdings, Inc.
Amarantus BioScience Holdings, Inc. operates as a biopharmaceutical firm, concentrating on creating innovative diagnostic tools and therapeutic solutions. Its primary focus areas encompass neurologica…
what is amarantus bioscience holdings, inc. · ambs stock overview · amarantus bioscience holdings, inc. company profile · who is amarantus bioscience holdings, inc. ceo · ambs OTC · amarantus bioscience holdings, inc. headquarters · amarantus bioscience holdings, inc. business segments
About Stock Overview & Key Data
Amarantus BioScience Holdings, Inc. (AMBS) is a Healthcare company in the Biotechnology industry, listed on OTC since Sep 10, 2010. As of the latest trading session, AMBS stock price is $0.00, with a market capitalization of $36,841. The stock has returned -66.67% over the past 12 months and +900.00% year-to-date.
In fiscal year 2022, Amarantus BioScience Holdings, Inc. reported revenue of $95331.00. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Amarantus BioScience Holdings, Inc. (AMBS) stock price is $0.00. The stock is traded on OTC under the ticker symbol AMBS. The 52-week range is $0.00 – $0.00.